Contraindicated. Coadministration of doravirine with a strong CYP3A inducer might decrease doravirine plasma concentrations and/or effects. Opportunity for lack of virologic response and doable resistance to doravirine. pentobarbital will lower the level or effect of armodafinil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Not known. pentobarbital will l... https://evanss876fui3.dm-blog.com/profile